Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Tax Rate (2022 - 2024)

Historic Tax Rate for Xeris Biopharma Holdings (XERS) over the last 3 years, with Q3 2024 value amounting to 17.44%.

  • Xeris Biopharma Holdings' Tax Rate rose 147400.0% to 17.44% in Q3 2024 from the same period last year, while for Jun 2025 it was 9.41%, marking a year-over-year increase of 102300.0%. This contributed to the annual value of 3.97% for FY2024, which is 20000.0% up from last year.
  • Latest data reveals that Xeris Biopharma Holdings reported Tax Rate of 17.44% as of Q3 2024, which was up 147400.0% from 5.25% recorded in Q2 2024.
  • Xeris Biopharma Holdings' Tax Rate's 5-year high stood at 17.44% during Q3 2024, with a 5-year trough of 5.25% in Q2 2024.
  • Over the past 3 years, Xeris Biopharma Holdings' median Tax Rate value was 1.63% (recorded in 2023), while the average stood at 2.48%.
  • Within the past 5 years, the most significant YoY rise in Xeris Biopharma Holdings' Tax Rate was 147400bps (2024), while the steepest drop was -85400bps (2024).
  • Over the past 3 years, Xeris Biopharma Holdings' Tax Rate (Quarter) stood at 2.55% in 2022, then plummeted by -32bps to 1.73% in 2023, then surged by 907bps to 17.44% in 2024.
  • Its Tax Rate stands at 17.44% for Q3 2024, versus 5.25% for Q2 2024 and 1.64% for Q1 2024.